Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with melanoma (a type of skin cancer) that has been confirmed through a tissue sample (biopsy), at any stage from I to IV.
- People who are able to give their signed agreement to have their past medical data used, or who are willing to agree to their information being included in the ongoing part of the study.
Who may not be able to join:
- People who are under legal guardianship or who do not have their personal freedom (for example, people who are incarcerated).
- People who fall under special legal protections, including minors (people under 18), women who are pregnant or breastfeeding, adults under legal protection such as guardianship or curatorship, and people who have been hospitalised without their own consent.
- People whose melanoma started in the eye (known as ocular melanoma).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Julie Charles, MD, PhD, CHU Grenoble Alpes
Phone: 476769320
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Identification of biomarkers of response to anti6PD1 according to the type of patient before the start of treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.